The research team is focusing on oral chemotherapy where concerns about compliance have become an important issue. As the project progresses, similar issues in the treatment of high cholesterol and glaucoma will be studied.
Dr. Fahima Nekka, Université de Montréal
When patients do not use medications as prescribed, the drugs may lose the ability to treat the disease. However, the impact of variations in patient use is not generally studied during clinical trials. By identifying the reasons for patient non-compliance and individual patient modifications, the team will determine the impact that poor compliance or dosing regimen adjustments have on therapeutic failure. A quantitative analysis of this impact will be developed. Initially, the team will focus on oral chemotherapy where concerns about compliance have become an important issue. As the project progresses, similar issues in the treatment of high cholesterol and glaucoma will be studied.